Filter
551
Filtered Results: 551
Text search:
suboptimal
identification
Featured
Recommendations
54
New Publications
178
Language
Document type
No document type
302
Guidelines
95
Studies & Reports
94
Manuals
25
Strategic & Response Plan
23
Training Material
5
Fact sheets
4
Situation Updates
3
Countries / Regions
India
37
Kenya
25
Western and Central Europe
20
Global
19
Ethiopia
18
South Africa
17
Nigeria
15
Malawi
14
Tanzania
12
Uganda
12
Africa
9
Zambia
9
Ghana
8
Sierra Leone
7
Congo, Democratic Republic of
7
Myanmar / Burma
7
Ukraine
6
Zimbabwe
6
Nepal
5
Latin America and the Carribbean
5
Eastern Europe
5
Namibia
5
Syria
4
Mozambique
4
Asia
4
Eastern Europe and Central Asia
4
Liberia
4
Pakistan
4
Lesotho
3
Philippines
3
Cambodia
3
South–East Asia Region
3
Bangladesh
3
Indonesia
3
Turkey
2
Rwanda
2
Albania
2
Afghanistan
2
Guinea
2
Germany
2
Western Pacific Region
2
Gabon
2
East and Southern Africa
2
Lebanon
2
Russia
2
Yemen
2
Georgia
2
Botswana
2
North Macedonia
1
Tajikistan
1
Colombia
1
Cameroon
1
Senegal
1
Kyrgyzstan
1
Burkina Faso
1
Jordan
1
West and Central Africa
1
Middle East and North Africa
1
North America
1
Jamaica
1
France
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Argentina
1
Vietnam
1
Brazil
1
Sudan
1
Central African Republic
1
Angola
1
South Sudan
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
221
Clinical Guidelines
57
Public Health
40
Women & Child Health
32
Key Resources
23
Pharmacy & Technologies
7
Capacity Building
2
Toolboxes
TB
69
HIV
61
AMR
36
COVID-19
30
NTDs
17
Mental Health
16
NCDs
15
Rapid Response
14
Ebola & Marburg
12
Caregiver
11
Polio
9
Pharmacy
7
Conflict
7
Refugee
6
Planetary Health
6
Disability
5
Health Financing Toolbox
4
Natural Hazards
3
Cholera
3
Malaria
2
Global Health Education
2
Zika
1
The National Strategic Plan for Malaria Elimination in India (2023-2027) focuses on achieving malaria elimination by 2030, in alignment with the Global Technical Strategy. The document outlines the strategies, targets, and goals for malaria elimination, aiming for zero indigenous malaria cases by 20...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
Infect Dis Poverty (2021) 10:15.
Real-time polymerase chain reaction (PCR) is a sensitive and specific method for diagnosing schistoso-
miasis. However, this method should be performed in a laboratory, usually located distant from the sample collection
site. Therefore, it is important to have fas...
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
This summary assesses the current state of evidence on each approach in tabular form, providing: the definition and objectives; evidence of effectiveness; operational considerations (e.g., training, staffing, and logistics); cost considerations and evidence on cost-effectiveness; operational success...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA r...
In a prospective cohort study in Bangwe primary care clinic, Blantyre, Malawi, all adults (18 years or older) presenting with an acute illness were screened for TB symptoms (cough, fever, night sweats, weight loss). Demographic characteristics were linked to exit interview by fingerprint bioidentifi...
